| Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer LV Rhodes, SP Short, NF Neel, VA Salvo, Y Zhu, S Elliott, Y Wei, D Yu, ... Cancer research 71 (2), 603-613, 2011 | 181 | 2011 |
| p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice WG Smalley-Freed, A Efimov, PE Burnett, SP Short, MA Davis, ... The Journal of clinical investigation 120 (6), 1824-1835, 2010 | 157 | 2010 |
| Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage CW Barrett, VK Reddy, SP Short, AK Motley, MK Lintel, AM Bradley, ... The Journal of clinical investigation 125 (7), 2646-2660, 2015 | 108 | 2015 |
| Colorectal cancer and metabolism RE Brown, SP Short, CS Williams Current colorectal cancer reports 14, 226-241, 2018 | 107 | 2018 |
| Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence Y Liu, OE Hawkins, Y Su, AE Vilgelm, T Sobolik, YM Thu, S Kantrow, ... EMBO molecular medicine 5 (1), 149-166, 2013 | 107 | 2013 |
| Selenoproteins in tumorigenesis and cancer progression SP Short, CS Williams Advances in cancer research 136, 49-83, 2017 | 104 | 2017 |
| Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease SP Short, JM Pilat, CS Williams Free Radical Biology and Medicine 127, 26-35, 2018 | 91 | 2018 |
| Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium DM Brantley-Sieders, CM Dunaway, M Rao, S Short, Y Hwang, Y Gao, ... Cancer research 71 (3), 976-987, 2011 | 80 | 2011 |
| Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut CW Barrett, SP Short, CS Williams Cellular and molecular life sciences 74, 607-616, 2017 | 70 | 2017 |
| RAF265 inhibits the growth of advanced human melanoma tumors Y Su, AE Vilgelm, MC Kelley, OE Hawkins, Y Liu, KL Boyd, S Kantrow, ... Clinical cancer research 18 (8), 2184-2198, 2012 | 68 | 2012 |
| Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer C Wang, G Gong, A Sheh, S Muthupalani, EM Bryant, DA Puglisi, ... Mucosal immunology 10 (6), 1504-1517, 2017 | 56 | 2017 |
| Adenoma formation following limited ablation of p120-catenin in the mouse intestine WG Smalley-Freed, A Efimov, SP Short, P Jia, Z Zhao, MK Washington, ... PloS one 6 (5), e19880, 2011 | 53 | 2011 |
| BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis B Parang, AM Kaz, CW Barrett, SP Short, W Ning, CE Keating, MK Mittal, ... Gut 66 (5), 852-862, 2017 | 47 | 2017 |
| Reovirus-induced apoptosis in the intestine limits establishment of enteric infection JJ Brown, SP Short, J Stencel-Baerenwald, K Urbanek, AJ Pruijssers, ... Journal of virology 92 (10), 10.1128/jvi. 02062-17, 2018 | 43 | 2018 |
| Colonic epithelial-derived selenoprotein P is the source for antioxidant-mediated protection in colitis-associated cancer SP Short, JM Pilat, CW Barrett, VK Reddy, Y Haberman, JR Hendren, ... Gastroenterology 160 (5), 1694-1708. e3, 2021 | 39 | 2021 |
| BVES regulates intestinal stem cell programs and intestinal crypt viability after radiation VK Reddy, SP Short, CW Barrett, MK Mittal, CE Keating, JJ Thompson, ... Stem Cells 34 (6), 1626-1636, 2016 | 34 | 2016 |
| Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters CW Barrett, JJ Smith, LC Lu, N Markham, KR Stengel, SP Short, B Zhang, ... PLoS One 7 (12), e51205, 2012 | 30 | 2012 |
| Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group KK Ciombor, Y Feng, AB Benson, Y Su, L Horton, SP Short, JSW Kauh, ... Investigational new drugs 32, 1017-1027, 2014 | 29 | 2014 |
| BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability YA Choksi, VK Reddy, K Singh, CW Barrett, SP Short, B Parang, ... Mucosal immunology 11 (5), 1363-1374, 2018 | 23 | 2018 |
| p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia SP Short, J Kondo, WG Smalley-Freed, H Takeda, MR Dohn, AE Powell, ... The Journal of clinical investigation 127 (12), 4462-4476, 2017 | 22 | 2017 |
